Responsible for the course: Lars A. Akslen and Jim Lorens have the academic responsibility and Ingeborg Winge is the course coordinator. Registration: You can register on this registration form. Place: Birkhaugsalen, room D301 and room D302 at Haukeland University Hospital, main building. lars thomassen uib Lars Thomassen Given that alteplase has been the only approved thrombolytic agent for acute ischemic stroke for almost two decades, there has been intense interest in more potent and safer agents
Einar Thomassen, University of Bergen, AHKR (Archaeology, History, Cultural Studies and Religion) Department, Faculty Member. Studies Early Christianity, Early Christian Papyri and Inscriptions, and Religious Studies. lars thomassen uib
This method is the second revolution for stroke treatment. Clotbusting medicine was the first revolution, Professor Lars Thomassen at the University of Bergen (UiB) tells forskning. no. He is also a senior physician at the Centre for Neurovascular Diseases in the Department of Neurology at Haukeland University Hospital in Bergen. NORSTROKE ResearchGate, the professional network for scientists. University of Bergen UiB Department of Clinical Medicine. 4. 83 MD. Contact. Lars Thomassen. Anna Therese Bergen Stroke Research Group. 199 likes. BSRG (Bergen Stroke Research Group) Jump to. Sections of this page. Studentombud ved UiB. College& University. LHL Sogn og Fjordane. Nonprofit Organization. Lars Thomassen og Ana Marreiros: lars thomassen uib Bthun, Marianne Lundervik; Haaland, ystein Ariansen; Logallo, Nicola; Svendsen, Frode; Thomassen, Lars; Helland, Christian Andre. 2018. Time course of cerebrovascular reactivity in patients treated for unruptured intracranial aneurysms: A Lars Thomassen Background: Contrastenhanced sonothrombolysis (CEST) leads to a more rapid recanalization in acute ischemic stroke caused by intracranial largevessel occlusion (LVO).